ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:ULURU Inc (ULUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011232
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
ULURU Inc (ULURU) is a developer and commercializer of wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s OraDisc is a polymer solid dosage form used to deliver amlexanox to the mucosal tissue. The company uses Nanoflex technology, which is designed for optimizing the wound bed environment and accelerate healing. It also develops transmucosal drug delivery system, which is a water erodible pharmaceutical carrier device, which is used to treat specific localized diseases or disorders. ULURU is headquartered in Addison, Texas, the US.

ULURU Inc (ULUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ULURU Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ULURU Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ULURU Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ULURU Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ULURU Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ULURU Inc, Medical Equipment, Deal Details 10
Partnerships 10
Uluru To Enter Into Licensing Agreement With Melmed For OraDisc Technology 10
Exciton Technologies Signs Letter Of Intent With ULURU 11
Uluru Expands Licensing Agreement with Altrazeal 12
Equity Offering 13
Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 13
Uluru to Raise USD1.59 Million in Private Placement of Shares 14
ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 15
Uluru Completes Private Placement Of Preferred Shares For US$1 Million 16
ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 18
Debt Offering 20
Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 20
ULURU Inc – Key Competitors 21
ULURU Inc – Key Employees 22
ULURU Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Nov 14, 2016: ULURU Reports Financial Results For Third Quarter 2016 24
Aug 16, 2016: ULURU Reports Financial Results For Second Quarter 2016 26
May 17, 2016: ULURU Reports Financial Results For First Quarter 2016 30
Mar 31, 2016: ULURU Reports Financial Results For Fourth Quarter And Year Ending December 31, 2015 32
Corporate Communications 35
Feb 18, 2016: ULURU Announces Resignation Of Director-2016 35
Government and Public Interest 36
Feb 22, 2016: ULURU Provides Update On Recent Business Activities – February 2016 36
Other Significant Developments 38
Feb 22, 2016: ULURU Provides Update On Recent Business Activities 38
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
ULURU Inc, Medical Equipment, Key Facts, 2016 2
ULURU Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ULURU Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ULURU Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ULURU Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ULURU Inc, Deals By Market, 2011 to YTD 2017 8
ULURU Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Uluru To Enter Into Licensing Agreement With Melmed For OraDisc Technology 10
Exciton Technologies Signs Letter Of Intent With ULURU 11
Uluru Expands Licensing Agreement with Altrazeal 12
Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 13
Uluru to Raise USD1.59 Million in Private Placement of Shares 14
ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 15
Uluru Completes Private Placement Of Preferred Shares For US$1 Million 16
ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 18
Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 20
ULURU Inc, Key Competitors 21
ULURU Inc, Key Employees 22
ULURU Inc, Subsidiaries 23

★調査レポート[ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析] (コード:DATA8011232)販売に関する免責事項を必ずご確認ください。
★調査レポート[ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆